Table 4.

The correlation between patient characteristics and pathologic response after neoadjuvant chemotherapy

CharacteristicsTotal (n)MRD + pCR, n (%)P
Genotypes
    Pro/Pro233 (13.0)0.019
    Pro/Arg + Arg/Arg8734 (39.1)
Menopausal status
    Premenopausal7728 (36.4)0.355
    Postmenopausal339 (27.3)
ER status
    Positive7219 (26.4)0.040
    Negative3215 (46.9)
    ND63
PR status
    Positive6015 (25.0)0.051
    Negative4418 (40.9)
    ND63
erbB2 status
    Positive4615 (32.6)0.987
    Negative5819 (32.8)
    ND63
Tumor size (cm)
    <37028 (40.0)0.062
    ≥3409 (22.5)